174 related articles for article (PubMed ID: 37629293)
1. Unveiling the Challenges in Tandem Ureteral Stent Management for Malignant Ureteral Obstruction: Failure Rate, Risk Factors, and Durability of Their Replacement.
Carmona O; Shvero A; Zilberman DE; Dotan ZA; Kleinmann N
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629293
[TBL] [Abstract][Full Text] [Related]
2. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
3. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
4. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy.
Elsamra SE; Motato H; Moreira DM; Waingankar N; Friedlander JI; Weiss G; Smith AD; Okeke Z
J Endourol; 2013 Oct; 27(10):1297-302. PubMed ID: 23829600
[TBL] [Abstract][Full Text] [Related]
5. Management of single double-J stent failure in malignant ureteral obstruction: tandem ureteral stenting with less frequent stent exchange.
Akıncı D; Ünal E; Çiftçi TT; Özkan OŞ; Akhan O
Diagn Interv Radiol; 2023 Mar; 29(2):312-317. PubMed ID: 36987982
[TBL] [Abstract][Full Text] [Related]
6. Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction.
Shvero A; Haifler M; Mahmud H; Dotan Z; Winkler H; Kleinmann N
Support Care Cancer; 2022 Nov; 30(11):9541-9548. PubMed ID: 36056940
[TBL] [Abstract][Full Text] [Related]
7. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
9. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Ureteral Tumour Stents for Malignant Ureteral Obstruction: Towards Reshaping an Optimal Stent.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():773-782. PubMed ID: 34737982
[TBL] [Abstract][Full Text] [Related]
12. Tandem ureteral stents drainage lowers renal pelvis pressure in malignant ureteral obstruction: Experimental and computational models.
Haifler M; Kleinmann N; Weiss D
J Biomech; 2021 Mar; 117():110237. PubMed ID: 33486265
[TBL] [Abstract][Full Text] [Related]
13. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Liu KL; Lee BC; Ye JD; Chang YH; Chang CC; Huang KH; Lee YJ; Chang YC
Eur Radiol; 2019 Feb; 29(2):628-635. PubMed ID: 29974220
[TBL] [Abstract][Full Text] [Related]
14. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction.
Kim KH; Cho KS; Ham WS; Hong SJ; Han KS
Urology; 2015 Sep; 86(3):459-64. PubMed ID: 26142711
[TBL] [Abstract][Full Text] [Related]
15. Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.
Wang JY; Zhang HL; Zhu Y; Qin XJ; Dai BO; Ye DW
Oncol Lett; 2016 Jan; 11(1):879-883. PubMed ID: 26870299
[TBL] [Abstract][Full Text] [Related]
16. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
17. [The Predictive Factors of Stent Failure in the Treatment of Malignant Extrinsc Ureteral Obstruction Using Internal Ureteral Stents].
Matsuura H; Arase S; Hori Y; Tochigi H
Hinyokika Kiyo; 2017 Dec; 63(12):503-507. PubMed ID: 29370660
[TBL] [Abstract][Full Text] [Related]
18. 10-Year Experience with Reinforced Ureteral Stents for Malignant Ureteral Obstruction.
Vogt B; Blanchet LH
Res Rep Urol; 2021; 13():581-589. PubMed ID: 34430510
[TBL] [Abstract][Full Text] [Related]
19. Use of full-length metallic stents in malignant ureteral obstruction.
Abbasi A; Wyre HW; Ogan K
J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
[TBL] [Abstract][Full Text] [Related]
20. Use of metallic and polymeric ureteral stents in malignant ureteral obstruction.
Ohtaka M; Kawahara T; Hayashi Y; Kobayashi R; Tsutsumi S; Ousaka K; Takizawa A; Kishida T; Yao M; Uemura H
BJUI Compass; 2021 Jan; 2(1):58-63. PubMed ID: 35474665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
